Shouyao Holdings (Beijing) Co., LTD. (SHA:688197)
38.47
-0.02 (-0.05%)
At close: Jan 19, 2026
Shouyao Holdings (Beijing) Co., LTD. Company Description
Shouyao Holdings (Beijing) Co., LTD. engages in the research, development, and production of innovative drugs in China. The company offers drugs for various indications, including non-small cell lung cancer, lymphoma, hepatocellular carcinoma, pancreatic cancer, breast cancer, ovarian cancer, thyroid cancer, leukemia, and diabetes.
The company was founded in 2016 and is headquartered in Beijing, China.
Shouyao Holdings (Beijing) Co., LTD.
| Country | China |
| Founded | 2016 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 172 |
| CEO | Wenjun Li |
Contact Details
Address: Building 15 Beijing, 100195 China | |
| Phone | 86 10 8885 7906 |
| Website | shouyaoholding.com |
Stock Details
| Ticker Symbol | 688197 |
| Exchange | Shanghai Stock Exchange |
| Fiscal Year | January - December |
| Reporting Currency | CNY |
| ISIN Number | CNE1000062V6 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Wenjun Li | Chairman of the Board and GM |
| Yajie Wang | Accounting Supervisor and Financial Director |
| Yan Zhu | Deputy General Manager |
| Xin He Xu | Senior Manager of Pharmacy Department and Director |
| Ying Li Zhang | Board Secretary |
| An Na Wang | Director of Clinical Medicine |
| Jing Can Wang | Director of Registration |
| Xi Jie Liu | Deputy General Manager |
| Li Min Yang | Deputy General Manager |
| Ying Hui Sun | Deputy General Manager |